Lridin is widely used in the development of anticancer agents due to its ability to interact with DNA and inhibit key enzymes involved in tumor growth. It serves as a core structure in certain kinase inhibitors, making it valuable in targeted cancer therapies. Additionally, derivatives of Lridin exhibit antimicrobial properties, showing effectiveness against resistant bacterial strains. Its role in optoelectronic materials is also being explored, particularly in organic light-emitting diodes (OLEDs), where it contributes to improved electron transport and device efficiency. Lridin-based compounds are further investigated for their potential in treating neurodegenerative diseases, thanks to their neuroprotective and antioxidant activities.